N Acetyl L Cysteine

DRUG4 trials

Sponsors

Ain Shams University, The First Affiliated Hospital of Soochow University, Peking University People's Hospital, University of Thessaly

Conditions

Aplastic AnemiaObesityOverweight (BMI > 25)Stem Cell Transplant ComplicationsSystemic Inflammatory Response SyndromeThrombocytopenia, Isolated

Phase 2

AZA Combined With NAC for PIT After HSCT

Not yet recruitingNCT05126004

The First Affiliated Hospital of Soochow UniversityStem Cell Transplant Complications, Thrombocytopenia, Isolated

Start: 2021-12-01End: 2026-06-30Target: 100Updated: 2021-11-18

NAC for Hematopoietic Recovery in SAA

Not yet recruitingNCT06518044

Peking University People's HospitalAplastic Anemia

Start: 2024-07-25End: 2025-07-01Target: 30Updated: 2024-07-24

Phase 4

Safety and Efficacy of Adding Intravenous N-acetyl Cysteine in Colon Surgeries

CompletedNCT03589495

Ain Shams UniversitySystemic Inflammatory Response Syndrome

Start: 2015-07-30End: 2016-10-15Updated: 2018-07-18

Unknown Phase

Redox Status and Exercise Training-induced Adaptations

RecruitingNCT07196852

University of ThessalyObesity, Overweight (BMI > 25)

Start: 2025-09-22End: 2026-12-30Target: 60Updated: 2025-12-16

Related Papers

Safety and efficacy of adding intravenous N-acetylcysteine to parenteral L-alanyl-L-glutamine in hospitalized patients undergoing surgery of the colon: a randomized controlled trial.

2019-07-018 citations